Antonis Apostolopoulos

[Yoshiho Ikeuchi 池内 与志穂 @YoshihoIkeuchi]

Our paper on "loop connectoids" are out.
https://t.co/n75Z6ebJDV
@Tomoyadu is presenting this (and more) at Takeda Symposium "ORGANOID 4D" today.

[Tomoya Duenki @Tomoyadu]

A bit late with posting, but I recently also attempted to create a Myakumyaku shaped organoid. @expo2025_japan

[Yoshiho Ikeuchi 池内 与志穂 @YoshihoIkeuchi]

Come and join us! We will share our hands-on-experience and its potential with the system! @Tomoyadu will be our highlight of the event!

[Tomoya Duenki @Tomoyadu]

We will be exhibiting from June 11 - August 12!

[Tomoya Duenki @Tomoyadu]

We have a new preprint online!

[Iwasaki_Lab_RIKEN @IwasakiLabRIKEN]

Our latest manuscript, related to #RNA #RibosomeProfiling #RiboSeq, was online @NatureComms!
We reported that a compound DMDA-PatA functions as an mRNA-selective translation inhibitor, clamping target DEAD-box RNA binding proteins on GNG motifs.
https://t.co/hZIS9YneZu

[Iwasaki_Lab_RIKEN @IwasakiLabRIKEN]

We are happy to announce that our latest manuscript, related to #RNA #RibosomeProfiling #RiboSeq, was published in @NatureComms !
We reported a new method to measure ribosome stoichiometry (ribosome number) and kinetics in a genome-wide manner.
https://t.co/09oN93IOS5

[Iwasaki_Lab_RIKEN @IwasakiLabRIKEN]

We are happy to announce that our latest manuscript, related to #RNA #RibosomeProfiling #RiboSeq, was published published with @SpringerNature in @NatureSMB !
We reported the translation factor eIF4A1 has a repressive role in stressed cells.
https://t.co/cdrKMB1qig

[Anja Konietzny @AnjaKonietzny]

My first tweet!! 🥳 And I’m excited to share that @MarinaMikhaylo8’s and my last project on axonal transport has been published in @J_Cell_Sci! Grateful for the amazing teamwork with our collaborators along the way! Thank you @peris_leticia, @yuhao_han, @yannespopp, @MoutinMJ 🙏

[Artem Nemudryi, PhD @artemnemudryi]

Cellular repair of DNA breaks enables editing of the human genome.

Do human cells repair RNA breaks, and can we use it to edit transcriptomes?

Our work with @ANemudraia and @WiedenheftLab is now online in @ScienceMagazine!

#ScienceResearch

https://t.co/L5qKw1tYrl

[Tomoya Duenki @Tomoyadu]

Our recent work is online!
https://t.co/bFOrj0Dajt

[Iwasaki_Lab_RIKEN @IwasakiLabRIKEN]

Please check out the blog post on Behind the Paper, regarding the CRISPRδ (delta)!
https://t.co/qLGcU0LZ62

[東京大学 生産技術研究所 @UTokyo_IIS]

【共同発表】超特異的な遺伝子ノックダウン法を開発 －CRISPR-Casシステムによる特異的翻訳抑制－（発表主体：理化学研究所）: 理化学研究所 開拓研究本部 岩崎RNAシステム生化学研究室の岩崎 信太郎… https://t.co/dU0xmyVWaD

[理化学研究所（理研） @RIKEN_JP]

プレスリリース｜超特異的な遺伝子ノックダウン法を開発
－CRISPR-Casシステムによる特異的翻訳抑制－

doi: https://t.co/qlbBEmghd5

詳細はこちらをご覧ください⬇️
https://t.co/GbBYzuos2E

#理研プレス #科学道

[Yuichi Shichino @u1_7no]

筆頭著者のアントニス@anto_apos が猛烈な数のプラスミドを作ってくれて（Methods, Supp Table 1を御覧ください）達成されたプロジェクトだということはぜひ強調しておきたいです。査読でも特異性のRibo-Seqデータは特に良いコメントを頂き、印象深いプロジェクトでした。

[Antonis Apostolopoulos @anto_apos]

Excited for the publication of our latest #research! Extremely grateful to everyone for this great collaboration!

[Iwasaki_Lab_RIKEN @IwasakiLabRIKEN]

Our latest #research on #RNA #CRISPR #cas13 #RibosomeProfiling #RiboSeq, published with @SpringerNature in @NatureComms!
This is a wonderful collaboration with Ikeuchi lab from U-Tokyo @YoshihoIkeuchi and Tsuiji lab from Aichigakuin Univ!

https://t.co/6Fn47bnl8P

[Yuichi Shichino @u1_7no]

Finally! Our paper showing that dCas13 is a great tool for gene knockdown with high selectivity via translational repression is out on @NatureComms! Congrats, @anto_apos and the team (@IwasakiLabRIKEN, @YoshihoIkeuchi lab, Tsuiji lab in Aichi Gakuin U)!
https://t.co/6ETCwqQAOD

[Yoshiho Ikeuchi 池内 与志穂 @YoshihoIkeuchi]

Our paper is out! A simple method to cut a bundle of axons quickly with a blue laser.

[Yuichi Shichino @u1_7no]

REMINDER! The deadline for application registration of a tenured Research Scientist in Iwasaki lab is Dec 8th (noon, JST).

[Iwasaki_Lab_RIKEN @IwasakiLabRIKEN]

岩崎研究室では修士課程・博士課程学生を募集しています。東大新領域メディカル情報生命専攻を介してjoinしてもらうこと可能です。B日程(冬試験)出願締め切りが近くなってきました。https://t.co/s7FnYCMPBH